entity

HCV

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about HCV: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

7Connections
0Hypotheses
0Analyses
4Outgoing
3Incoming

Wiki Pages (8)

Knowledge base pages for this entity

GPT - Alanine Transaminase (ALT)

gene · 3393 words

LY03020 - Luye Pharma Phase 1 Trial

clinical · 3130 words

IL28A (Interleukin-28A)

gene · 2243 words

Gilead Sciences

company · 2053 words

MK-6837 Phase 1 Solid Tumor Trial (NCT06460961)

clinical · 1490 words

Outgoing (4)

TargetRelationTypeStr
Carcinomaassociated_withdisease0.80
LIVER_DISEASEcausesdisease0.72
LIVER_CANCERcausesdisease0.64
CIRRHOSIScausesdisease0.64

Incoming (3)

SourceRelationTypeStr
RPL17bindsgene0.80
OCLNregulatesgene0.72
MARVEL_DOMAINinteracts_withprotein0.64

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found